Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs7575241 | chr2:135768352 | C/A | 0.000258 | 175 | 25.87 | 26.57 | 10.3 | KM Plot |
PCPG | rs75754909 | chr12:56726349 | A/G | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs7576676 | chr2:107243041 | G/A | 0.000239 | 176 | 26.57 | 23.53 | 25.87 | KM Plot |
PCPG | rs75770997 | chr8:11513636 | A/C | 0.000428 | 178 | 25.17 | 25.87 | 19.93 | KM Plot |
PCPG | rs7577426 | chr2:24313687 | G/T | 0.00011 | 178 | 25.28 | 26.92 | 17.43 | KM Plot |
PCPG | rs75780010 | chr10:102308800 | G/T | 0.000361 | 175 | 24.1 | 27.75 | 21.55 | KM Plot |
PCPG | rs7578775 | chr2:242531522 | A/G | 4.24E-5 | 178 | 19.75 | 29.57 | 25.87 | KM Plot |
PCPG | rs7580021 | chr2:242556732 | G/A | 4.04E-5 | 178 | 25.87 | 26.47 | 20.2 | KM Plot |
PCPG | rs7580246 | chr2:242557019 | G/A | 4.04E-5 | 178 | 25.87 | 26.47 | 20.2 | KM Plot |
PCPG | rs75805443 | chr7:105162828 | A/G | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs75809680 | chr20:10636324 | C/T | 0.000222 | 170 | 24.23 | 31.9 | 14.28 | KM Plot |
PCPG | rs7581110 | chr2:2659311 | G/A | 1.17E-8 | 175 | 26.57 | 13.4 | 3.63 | KM Plot |
PCPG | rs7583766 | chr2:242529451 | C/T | 4.83E-5 | 176 | 25.87 | 25.67 | 20.2 | KM Plot |
PCPG | rs75852966 | chr2:121545713 | G/A | 0.000238 | 175 | 25.53 | 24.37 | 59.77 | KM Plot |
PCPG | rs7586618 | chr2:11031548 | A/G | 6.7E-7 | 178 | 25.28 | 26.88 | 8.82 | KM Plot |